Immunology
Eli Lilly to acquire DICE Therapeutics for immunology innovations
June 21, 2023Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology
Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …
GSK shares positive data for RSV vaccine
June 21, 2023Research and Development GSK, Immunology, RSV, Vaccine, clinical trial
GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …
Vaxxas opens manufacturing facility for needle-free vaccine patch
June 19, 2023Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines
Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …
ImmuPharma initiates phase 2/3 clinical trial for lupus treatment
June 19, 2023Research and Development Avion Pharmaceuticals, ImmuPharma, Immunology, Lupus, clinical trial
ImmuPharma has announced that it will commence a phase 2/3 adaptive clinical trial of P140 (Lupuzor) in patients with systemic …
FDA gives Eagle Pharmaceuticals Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for SCABP drug
June 15, 2023Research and Development Eagle Pharmaceuticals, FDA, FDA fast-track, Immunology, SCABP
US-based pharmaceutical company Eagle Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted its severe community-acquired …
FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation
May 19, 2023Research and Development FDA, Immunology, Pfizer, RSV, Vaccine, maternal immunisation
Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the US Food and Drug Administration …
FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children
April 28, 2023Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine
Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
